Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

MLA

Banerjee S, et al. “Sertraline or Mirtazapine for Depression in Dementia (HTA-SADD): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial.” Lancet, vol. 378, no. 9789, July 2011, pp. 403–11. EBSCOhost, https://doi.org/10.1016/s0140-6736(11)60830-1.

APA

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, & O’Brien J. (2011). Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet, 378(9789), 403–411. https://doi.org/10.1016/s0140-6736(11)60830-1

Chicago

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, et al. 2011. “Sertraline or Mirtazapine for Depression in Dementia (HTA-SADD): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial.” Lancet 378 (9789): 403–11. doi:10.1016/s0140-6736(11)60830-1.